from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0418/lpqL

LFCtreatmentdescriptionclass of inhibitor

-0.286

Amikacinug/mL Amikacintranslation

-1.386

Cap5-10ug/mL Capreomycintranslation

-0.817

Rox10-50 ug/mL Roxithromycintranslation

-0.137

SM2-5 ug/mL Streptomycintranslation

0.523

Tet5-10 ug/mL Tetracyclinetranslation

0.318

Rif0.2-5ug/mL Rifampicintranscription

0.848

Rifp0.1-0.5ug/mL Rifapentinetranscription

-2.165

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.823

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.672

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.443

Clofazimine10-13 ug/mL Clofaziminerespiration

0.394

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.231

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.174

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.634

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.023

Econazole10-24 ug/mL Econazole (azole drug)respiration

-1.061

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.859

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.191

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.178

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.978

KCN5-20 ug/mL Potassium cyaniderespiration

0.490

NaN30.2-2 mM Sodium aziderespiration

0.037

Nigericin50 uM Nigericinrespiration

0.286

TRC10-150 ug/mL Triclosanrespiration

-1.932

TRZ10-25 ug/mL Thioridazinerespiration

-2.009

Valinomycin0.5-10 uM Valinomycinrespiration

0.990

ZnSO42 mM ZnSO4respiration

-0.699

menadione6-10 ug/mL Menadionerespiration

-0.567

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.877

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.323

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.153

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.126

NRP_1Non-replicating persistence stage 1dosRassociated

0.193

Amp0.2mg/mL AmpicillincellWall

0.487

Cephalexin20-100 ug/mL CephalexincellWall

0.769

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.767

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.093

EMB10-20 ug/mL EthambutolcellWall

0.520

Eta12-40 ug/mL EthionamidecellWall

0.689

INH0.2-0.4 ug/mL IsoniazidcellWall

0.613

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.081

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.169

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.897

BZA0.12 mg/mL BenzamidearomaticAmides

0.501

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.366

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.758

H2O24 mM hydrogen peroxideDNAdamaging

0.549

Levo10 ug/mL LevofloxacinDNAdamaging

0.609

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.204

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.649

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.864

UVUV-irradiationDNAdamaging

-0.824

ARP41-4 ug/mL Antitubercular compound ARP4?

0.515

Antimycin12.5-50 ug/mL Antimycin A?

0.741

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.545

PA_110-50 ug/mL Antitubercular compound PA-1?

0.091

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.329

PA8240.2-2 ug/mL PA-824?

-0.100

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.580

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.432

Verapamil50 uM Verapamil?

0.116

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.011

methoxatin10-20 ug/mL Methoxatin?